DOI QR코드

DOI QR Code

Higher Prevalence and Progression Rate of Chronic Kidney Disease in Elderly Patients with Type 2 Diabetes Mellitus

  • Kim, Kyung-Soo (Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine) ;
  • Park, Seok Won (Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine) ;
  • Cho, Yong-Wook (Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine) ;
  • Kim, Soo-Kyung (Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine)
  • Received : 2017.10.23
  • Accepted : 2018.03.18
  • Published : 2018.06.17

Abstract

Background: To evaluate the prevalence of chronic kidney disease (CKD) and progression rate to CKD in elderly patients with type 2 diabetes mellitus (T2DM). Methods: We investigated the medical records of 190 elderly patients (65 years or older) with T2DM from 2005 to 2011 in 6-month increments. Mean follow-up duration was 64.5 months. CKD was defined as estimated glomerular filtration rate (eGFR) <60 mL/min/$1.73m^2$ and/or the presence of albuminuria. Results: The mean age was 70.4 years and mean diabetes duration was 10.6 years. Among all the participants, 113 patients (59.5%) had CKD. The eGFR was significantly decreased between baseline ($65.7{\pm}15.0mL/min/1.73m^2$) and the end of follow-up ($52.7{\pm}17.5mL/min/1.73m^2$, P<0.001). At the end of follow-up, the prevalence of eGFR <60 mL/min/$1.73m^2$ had increased by 61.6% (at baseline, 44.2%). Furthermore, in patients with eGFR ${\geq}60mL/min/1.73m^2$, the progression rate to more than CKD stage 3 was 39.6% at the end of follow-up; 30.2% of elderly diabetic patients had progressed to albuminuria from normoalbuminuria. Kaplan-Meier analysis showed that the time interval to worsening nephropathy was significantly shorter in elderly patients with diabetes duration ${\geq}10years$ than in those with diabetes duration <5 years (P=0.018). Conclusion: CKD was commonly observed in older patients with T2DM, and the progression rate to CKD is also high. Consequently, it is important to identify and manage CKD as early as possible in elderly patients with T2DM, especially in those with diabetes duration ${\geq}10years$.

Keywords

References

  1. Meguid El Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005;365:331-40. https://doi.org/10.1016/S0140-6736(05)17789-7
  2. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G. Chronic kidney disease as a global public health problem: approaches and initiatives: a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007;72:247-59. https://doi.org/10.1038/sj.ki.5002343
  3. Zhou XJ, Rakheja D, Yu X, Saxena R, Vaziri ND, Silva FG. The aging kidney. Kidney Int 2008;74:710-20. https://doi.org/10.1038/ki.2008.319
  4. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 2011;305:2532-9. https://doi.org/10.1001/jama.2011.861
  5. Afkarian M, Sachs MC, Kestenbaum B, Hirsch IB, Tuttle KR, Himmelfarb J, de Boer IH. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol 2013;24:302-8. https://doi.org/10.1681/ASN.2012070718
  6. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305. https://doi.org/10.1056/NEJMoa041031
  7. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049-60. https://doi.org/10.1056/NEJMoa043161
  8. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-69. https://doi.org/10.1161/01.CIR.0000095676.90936.80
  9. O'Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, Walter LC, Mehta KM, Steinman MA, Allon M, McClellan WM, Landefeld CS. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 2007;18:2758-65. https://doi.org/10.1681/ASN.2007040422
  10. Iglesias P, Heras M, Diez JJ. Diabetes mellitus and kidney disease in the elderly. Nefrologia 2014;34:285-92.
  11. Lee SW, Kim YC, Oh SW, Koo HS, Na KY, Chae DW, Kim S, Chin HJ. Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korean National Health and Nutrition Examination Survey (KNHANES). Nephrol Dial Transplant 2011;26:3975-80. https://doi.org/10.1093/ndt/gfr154
  12. Wasen E, Isoaho R, Mattila K, Vahlberg T, Kivela SL, Irjala K. Renal impairment associated with diabetes in the elderly. Diabetes Care 2004;27:2648-53. https://doi.org/10.2337/diacare.27.11.2648
  13. Sheen YJ, Sheu WH. Risks of rapid decline renal function in patients with type 2 diabetes. World J Diabetes 2014;5:835-46. https://doi.org/10.4239/wjd.v5.i6.835
  14. Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, de Boer IH. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA 2016;316: 602-10. https://doi.org/10.1001/jama.2016.10924
  15. Lou Arnal LM, Campos Gutierrez B, Cuberes Izquierdo M, Gracia Garcia O, Turon Alcaine JM, Bielsa Garcia S, Gimeno Orna JA, Boned Juliani B, Sanjuan Hernandez-French A; Grupo de Investigacion ERC Aragon. Prevalence of chronic kidney disease in patients with type 2 diabetes mellitus treated in primary care. Nefrologia 2010;30:552-6.
  16. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:1-12. https://doi.org/10.1016/S0272-6386(03)70048-1
  17. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 2004;291:844-50. https://doi.org/10.1001/jama.291.7.844
  18. Kim S, Lim CS, Han DC, Kim GS, Chin HJ, Kim SJ, Cho WY, Kim YH, Kim YS. The prevalence of chronic kidney disease (CKD) and the associated factors to CKD in urban Korea: a population-based cross-sectional epidemiologic study. J Korean Med Sci 2009;24 Suppl:S11-21. https://doi.org/10.3346/jkms.2009.24.S1.S11
  19. Yun KJ, Kim HJ, Kim MK, Kwon HS, Baek KH, Roh YJ, Song KH. Risk factors for the development and progression of diabetic kidney disease in patients with type 2 diabetes mellitus and advanced diabetic retinopathy. Diabetes Metab J 2016;40:473-81. https://doi.org/10.4093/dmj.2016.40.6.473
  20. Levey AS, Inker LA, Coresh J. Chronic kidney disease in older people. JAMA 2015;314:557-8. https://doi.org/10.1001/jama.2015.6753
  21. Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, Huang ES, Korytkowski MT, Munshi MN, Odegard PS, Pratley RE, Swift CS. Diabetes in older adults. Diabetes Care 2012;35:2650-64. https://doi.org/10.2337/dc12-1801
  22. Sinclair A, Morley JE, Rodriguez-Manas L, Paolisso G, Bayer T, Zeyfang A, Bourdel-Marchasson I, Vischer U, Woo J, Chapman I, Dunning T, Meneilly G, Rodriguez-Saldana J, Gutierrez Robledo LM, Cukierman-Yaffe T, Gadsby R, Schernthaner G, Lorig K. Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc 2012;13:497-502. https://doi.org/10.1016/j.jamda.2012.04.012
  23. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-266. https://doi.org/10.1016/S0272-6386(02)70081-4
  24. Hwang SJ, Lin MY, Chen HC, Hwang SC, Yang WC, Hsu CC, Chiu HC, Mau LW. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan. Nephrol Dial Transplant 2008;23:3192-8. https://doi.org/10.1093/ndt/gfn222
  25. Korean Diabetes Association: Diabetes fact sheet in Korea 2016. Available from: http://www.diabetes.or.kr/temp/KDA_fact_sheet%202016.pdf (cited 2018 Apr 11).
  26. Lundstrom UH, Gasparini A, Bellocco R, Qureshi AR, Carrero JJ, Evans M. Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study. BMC Nephrol 2017;18:59. https://doi.org/10.1186/s12882-017-0473-1
  27. Anderson S, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kaysen GA, Kusek JW, Nayfield SG, Schmader K, Tian Y, Ashworth JR, Clayton CP, Parker RP, Tarver ED, Woolard NF, High KP; workshop participants. Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol 2009;20:1199-209. https://doi.org/10.1681/ASN.2008080860
  28. Arora P, Jalal K, Gupta A, Carter RL, Lohr JW. Progression of kidney disease in elderly stage 3 and 4 chronic kidney disease patients. Int Urol Nephrol 2017;49:1033-40. https://doi.org/10.1007/s11255-017-1543-9
  29. Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali WA, Southern DA, McLaughlin K, Mortis G, Culleton BF. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 2006;69:2155-61. https://doi.org/10.1038/sj.ki.5000270
  30. Costacou T, Orchard TJ. Cumulative kidney complication risk by 50 years of type 1 diabetes: the effects of sex, age, and calendar year at onset. Diabetes Care 2018;41:426-33. https://doi.org/10.2337/dc17-1118
  31. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53. https://doi.org/10.1016/S0140-6736(98)07019-6
  32. Baid-Agrawal S, Reinke P, Schindler R, Tullius S, Frei U. WCN 2003 satellite symposium on kidney transplantation in the elderly, Weimar, Germany, June 12-14, 2003. Nephrol Dial Transplant 2004;19:43-6. https://doi.org/10.1093/ndt/gfg528
  33. Gajjala PR, Sanati M, Jankowski J. Cellular and molecular mechanisms of chronic kidney disease with diabetes mellitus and cardiovascular diseases as its comorbidities. Front Immunol 2015;6:340.
  34. Kim KS, Kim SK, Sung KM, Cho YW, Park SW. Management of type 2 diabetes mellitus in older adults. Diabetes Metab J 2012;36:336-44. https://doi.org/10.4093/dmj.2012.36.5.336

Cited by

  1. Clinical Usefulness of the Cardio-Ankle Vascular Index as a Predictor of Primary Cardiovascular Events in Patients With Chronic Kidney Disease vol.10, pp.12, 2018, https://doi.org/10.14740/jocmr3631
  2. Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome vol.43, pp.6, 2019, https://doi.org/10.4093/dmj.2018.0181
  3. Treatment with Cinacalcet in Hemodialysis Patients with Severe Secondary Hyperparathyroidism, Influences Bone Mineral Metabolism and Anemia Parameters vol.14, pp.None, 2019, https://doi.org/10.2174/1574885514666190802144629
  4. Influence of diabetes mellitus on patients with lumbar spinal stenosis: A nationwide population-based study vol.14, pp.3, 2018, https://doi.org/10.1371/journal.pone.0213858
  5. Predictores de progresión de enfermedad renal en el paciente anciano vol.22, pp.1, 2018, https://doi.org/10.4321/s2254-28842019000100004
  6. Renal status in elderly patients with type 2 diabetes vol.24, pp.1, 2020, https://doi.org/10.1007/s10157-019-01792-9
  7. Proteinuria Is Associated with Carotid Artery Atherosclerosis in Non-Albuminuric Type 2 Diabetes: A Cross-Sectional Study vol.9, pp.1, 2018, https://doi.org/10.3390/jcm9010136
  8. Metformin Use and Risk of All-Cause Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease—A Systematic Review and Meta-Analysis vol.11, pp.None, 2018, https://doi.org/10.3389/fendo.2020.559446
  9. Insulin: Trigger and Target of Renal Functions vol.8, pp.None, 2018, https://doi.org/10.3389/fcell.2020.00519
  10. Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statement vol.39, pp.1, 2020, https://doi.org/10.23876/j.krcp.20.012
  11. The fat mass, estimated glomerular filtration rate, and chronic inflammation in type 2 diabetic patients vol.34, pp.6, 2018, https://doi.org/10.1002/jcla.23229
  12. Association Between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes vol.22, pp.10, 2018, https://doi.org/10.1089/dia.2019.0499
  13. Rate of kidney function decline and factors predicting progression of kidney disease in type 2 diabetes mellitus patients with reduced kidney function: A nationwide retrospective cohort study vol.24, pp.6, 2020, https://doi.org/10.1111/1744-9987.13480
  14. Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus vol.12, pp.1, 2021, https://doi.org/10.1007/s13300-020-00948-1
  15. Factors determining the clinical significance of dipeptidyl peptidase-4 inhibitors in the treatment of elderly patients with type 2 diabetes mellitus vol.2021, pp.7, 2018, https://doi.org/10.21518/2079-701x-2021-7-56-67
  16. Estimation of the prevalence of type 2 diabetes in combination with diabetic kidney disease and identification of the associated factors in patients attending primary hospitals in Anhui Province, Chin vol.49, pp.10, 2018, https://doi.org/10.1177/03000605211051225
  17. Effect of Oral carnosine supplementation on urinary TGF-β in diabetic nephropathy: a randomized controlled trial vol.22, pp.1, 2021, https://doi.org/10.1186/s12882-021-02434-7